GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » ROCE %

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) ROCE % : 0.00% (As of . 20)


View and export this data going back to 2001. Start your Free Trial

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized ROCE % for the quarter that ended in . 20 was 0.00%.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T ROCE % Historical Data

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T ROCE % Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
ROCE %

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
ROCE %

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T ROCE % Calculation

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( (+)/ )
=/
= %

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( ( + )/ )
=/
= %

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T ROCE % Related Terms

Thank you for viewing the detailed overview of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Business Description

Traded in Other Exchanges
N/A
Address
Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Headlines

No Headlines